- Investing Ideas
- /
- U.K. Healthcare Small Cap High Growth Stocks
U.K. Healthcare Small Cap High Growth Stocks
UPDATED Jul 26, 2022
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
16 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| BELLBelluscura | UKĀ£0.90 | 6.5% | 31.4% | UKĀ£109.6m | UKĀ£2.00 | PS313.6x | E81.3% | n/a | ||
| TSTLTristel | UKĀ£3.29 | -9.9% | -46.9% | UKĀ£155.4m | UKĀ£4.48 | PE67.9x | E35.1% | 2.0% | ||
| IDHCIntegrated Diagnostics Holdings | US$0.80 | 5.3% | -33.3% | US$480.0m | US$1.49 | PE6.6x | E14.2% | 14.5% | ||
| TLYTotally | UKĀ£0.43 | 3.0% | 18.8% | UKĀ£80.0m | n/a | PE74.1x | E44.3% | 2.3% | ||
| INSInstem | UKĀ£7.25 | -5.2% | -2.7% | UKĀ£164.4m | UKĀ£10.10 | PE98x | E39.8% | n/a | ||
| IHCInspiration Healthcare Group | UKĀ£0.81 | 3.2% | -32.1% | UKĀ£54.8m | UKĀ£2.66 | PE15.3x | E11.5% | 0.8% | ||
| MGPMedica Group | UKĀ£1.57 | 5.7% | -9.5% | UKĀ£191.6m | UKĀ£2.04 | PE35.1x | E19.7% | 1.7% | ||
| RENXRenalytix | UKĀ£1.08 | 0% | -90.2% | UKĀ£80.4m | UKĀ£2.69 | PS37x | E18.2% | n/a | ||
| SMDSpectral MD Holdings | UKĀ£0.35 | 0% | -25.3% | UKĀ£47.9m | UKĀ£1.68 | PS3.8x | E81.4% | n/a | ||
| CREOCreo Medical | UKĀ£0.76 | -2.6% | -59.4% | UKĀ£135.4m | UKĀ£2.50 | PS5.4x | E18.1% | n/a | ||
| AVOAdvanced Oncotherapy | UKĀ£0.23 | -6.3% | -30.8% | UKĀ£111.9m | UKĀ£1.66 | PB1.8x | E51.5% | n/a | ||
| INHCInduction Healthcare Group | UKĀ£0.48 | -1.0% | -28.7% | UKĀ£44.8m | n/a | PS8.1x | E60.8% | n/a | ||
| AGLANGLE | UKĀ£0.73 | 1.0% | -31.9% | UKĀ£190.7m | UKĀ£2.16 | PS188.3x | E2.3% | n/a | ||
| KOOKooth | UKĀ£1.31 | -3.0% | -62.0% | UKĀ£43.3m | UKĀ£3.82 | PS2.6x | E7.8% | n/a | ||
| ODXOmega Diagnostics Group | UKĀ£0.034 | 0% | -93.4% | UKĀ£8.1m | n/a | PB0.4x | E60.8% | n/a | ||
| YGENYourgene Health | UKĀ£0.077 | 10.7% | -36.7% | UKĀ£56.4m | n/a | PS2x | E74.3% | n/a |
Page 1 of 1